Fujiang Chu

739 total citations
31 papers, 597 citations indexed

About

Fujiang Chu is a scholar working on Molecular Biology, Immunology and Microbiology. According to data from OpenAlex, Fujiang Chu has authored 31 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Microbiology. Recurrent topics in Fujiang Chu's work include Antimicrobial Peptides and Activities (6 papers), Computational Drug Discovery Methods (5 papers) and Protein Hydrolysis and Bioactive Peptides (4 papers). Fujiang Chu is often cited by papers focused on Antimicrobial Peptides and Activities (6 papers), Computational Drug Discovery Methods (5 papers) and Protein Hydrolysis and Bioactive Peptides (4 papers). Fujiang Chu collaborates with scholars based in China, Czechia and United States. Fujiang Chu's co-authors include Xiaobao Jin, Jiayong Zhu, Xuemei Lu, Xiaoyan Cai, Yongli Zhang, Wei Fang, Hongsheng Chen, Juan Shen, Shao Li and Min Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Applied Microbiology and Biotechnology and Molecules.

In The Last Decade

Fujiang Chu

31 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fujiang Chu China 13 303 117 100 84 67 31 597
Hyung Keun Kim South Korea 10 285 0.9× 229 2.0× 90 0.9× 27 0.3× 29 0.4× 14 509
Magdalena Mizerska-Kowalska Poland 16 250 0.8× 30 0.3× 109 1.1× 78 0.9× 34 0.5× 31 543
Zhenya Zhai China 13 332 1.1× 53 0.5× 53 0.5× 22 0.3× 65 1.0× 28 600
Kamaldeep Gill India 11 226 0.7× 67 0.6× 43 0.4× 25 0.3× 52 0.8× 22 542
Mi Sook Jeong South Korea 16 147 0.5× 59 0.5× 88 0.9× 35 0.4× 15 0.2× 18 519
Maarten A. Hoijer Netherlands 11 179 0.6× 60 0.5× 252 2.5× 20 0.2× 49 0.7× 15 669
Shi Fang China 19 469 1.5× 142 1.2× 96 1.0× 13 0.2× 70 1.0× 47 1.1k
Boon Yin Khoo Malaysia 17 468 1.5× 28 0.2× 63 0.6× 45 0.5× 100 1.5× 59 969
Ruyi Zhang China 16 641 2.1× 32 0.3× 89 0.9× 85 1.0× 52 0.8× 44 935

Countries citing papers authored by Fujiang Chu

Since Specialization
Citations

This map shows the geographic impact of Fujiang Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fujiang Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fujiang Chu more than expected).

Fields of papers citing papers by Fujiang Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fujiang Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fujiang Chu. The network helps show where Fujiang Chu may publish in the future.

Co-authorship network of co-authors of Fujiang Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Fujiang Chu. A scholar is included among the top collaborators of Fujiang Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fujiang Chu. Fujiang Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Siyuan, et al.. (2022). Effects of Chang-Kang-Fang Formula on the Microbiota-Gut-Brain Axis in Rats With Irritable Bowel Syndrome. Frontiers in Pharmacology. 13. 778032–778032. 15 indexed citations
2.
Zhang, Lun, Shuiqing Gui, Yinghua Xu, et al.. (2021). Colon tissue-accumulating mesoporous carbon nanoparticles loaded with Musca domestica cecropin for ulcerative colitis therapy. Theranostics. 11(7). 3417–3438. 31 indexed citations
3.
Chu, Fujiang, Xiaobao Jin, & Hongyan Ma. (2019). Anti-diarrhea effects and identification of Musca domestica larvae low molecular weight peptides (LMWP). Journal of Pharmaceutical and Biomedical Analysis. 173. 162–168. 8 indexed citations
4.
Shen, Juan, Lingyan Liu, Zhiyu Chen, et al.. (2019). Prodigiosin isolated from Serratia�marcescens in the Periplaneta�americana gut and its apoptosis‑inducing activity in HeLa cells. Oncology Reports. 41(6). 3377–3385. 19 indexed citations
5.
6.
Li, Linyuan, et al.. (2018). In vivo and in vitro anti-inflammatory effects of Sophora flavescens residues. Journal of Ethnopharmacology. 224. 497–503. 46 indexed citations
7.
Cai, Xiaoyan, et al.. (2017). Luteolin Promotes Cell Apoptosis by Inducing Autophagy in Hepatocellular Carcinoma. Cellular Physiology and Biochemistry. 43(5). 1803–1812. 109 indexed citations
8.
Chu, Fujiang, Xiaobao Jin, Hongyan Ma, Xuemei Lu, & Jiayong Zhu. (2015). Effect ofMusca domesticmaggot polypeptide extract on HUVEC dysfunction induced by early-activated macrophages. Pharmaceutical Biology. 54(4). 1–4. 5 indexed citations
9.
Lu, Xuemei, Xiaobao Jin, Yanting Huang, et al.. (2014). Construction of a Novel Liver-Targeting Fusion Interferon by Incorporation of aPlasmodiumRegion I-Plus Peptide. BioMed Research International. 2014. 1–8. 10 indexed citations
10.
Jin, Xiaobao, Xuemei Lu, Fujiang Chu, et al.. (2014). Construction and characterization of a thermostable whole-cell chitinolytic enzyme using yeast surface display. World Journal of Microbiology and Biotechnology. 30(10). 2577–2585. 12 indexed citations
11.
Jin, Xiaobao, Lulu Liang, Juan Shen, et al.. (2014). Cecropin Suppresses Human Hepatocellular Carcinoma BEL-7402 Cell Growth and Survival in vivo without Side-Toxicity. Asian Pacific Journal of Cancer Prevention. 15(13). 5433–5436. 11 indexed citations
12.
Lu, Xuemei, Xiaobao Jin, Jie Wang, Fujiang Chu, & Jiayong Zhu. (2014). Antihepatitis B Virus Activity of a Protein-Enriched Fraction from Housefly (Musca domestica) in a Stable HBV-Producing Cell Line. The Scientific World JOURNAL. 2014. 1–6. 5 indexed citations
13.
Jin, Xiaobao, et al.. (2013). Scientific evaluation of the subchronic toxicity of musca domestica larvae extracts in Sprague Dawley rats. Food and Chemical Toxicology. 59. 464–469. 4 indexed citations
14.
Chu, Fujiang, Xiaobao Jin, & Jiayong Zhu. (2011). Housefly Maggots (Musca domestica) Protein-enriched Fraction/ extracts (PE) Inhibit Lipopolysaccharide-induced Atherosclerosis Pro-inflammatory Responses. Journal of Atherosclerosis and Thrombosis. 18(4). 282–290. 28 indexed citations
15.
Lu, Xuemei, Juan Shen, Xiaobao Jin, et al.. (2011). Bactericidal activity of Musca domestica cecropin (Mdc) on multidrug-resistant clinical isolate of Escherichia coli. Applied Microbiology and Biotechnology. 95(4). 939–945. 33 indexed citations
16.
Shen, Juan, Xuemei Lu, Xiaobao Jin, et al.. (2011). Expression of a novel dual-functional protein – The antimicrobial peptide LL-37 fused with human acidic fibroblast growth factor in Escherichia coli. Protein Expression and Purification. 81(1). 119–125. 6 indexed citations
17.
Chu, Fujiang. (2011). Study on the preclinical teratogenicity of musca domestica larvae powder. 3 indexed citations
18.
Lu, Xuemei, et al.. (2010). Expression of the antimicrobial peptide cecropin fused with human lysozyme in Escherichia coli. Applied Microbiology and Biotechnology. 87(6). 2169–2176. 41 indexed citations
19.
Jin, Xiaobao, Yan Wang, Xuemei Lu, et al.. (2010). Apoptosis-inducing activity of the antimicrobial peptide cecropin of <italic>Musca domestica</italic> in human hepatocellular carcinoma cell line BEL-7402 and the possible mechanism. Acta Biochimica et Biophysica Sinica. 42(4). 259–265. 60 indexed citations
20.
Wang, Yan, et al.. (2009). Expression pattern of antibacterial genes in the Musca domestica. Science in China Series C Life Sciences. 52(9). 823–830. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hyung Keun Kim Breakdown of academic impact, for papers by Magdalena Mizerska-Kowalska Breakdown of academic impact, for papers by Zhenya Zhai Breakdown of academic impact, for papers by Kamaldeep Gill Breakdown of academic impact, for papers by Mi Sook Jeong Breakdown of academic impact, for papers by Maarten A. Hoijer Breakdown of academic impact, for papers by Shi Fang Breakdown of academic impact, for papers by Boon Yin Khoo Breakdown of academic impact, for papers by Ruyi Zhang
Rankless by CCL
2026